Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25
In Brief: Search Committee Finds Prospects Uncertain About Election, Unwilling To Take Pay Cut
Intarferon Results Promising, ACS Says, And commits Another $3.4 Million
Randomization With Options Stimulates Sedmental Accrual
It’s Official; Most of NCI NTP contingent Will Move To N.C.
Guidelines Adopted For Pathology Review
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Rathmell steps down at NCI as Trump team considers candidates to replace her
Wafik El-Deiry, Harvey Risch have been interviewed - David Liu awarded 2025 Breakthrough Prize in Life Sciences